
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | -- | $3.2M | $23.6M | $77.4M | $130.1M | |
Revenue Growth (YoY) | -- | -- | 649.46% | 227.56% | 68.06% | |
Cost of Revenues | -- | $599K | $2.1M | $9.3M | $13.4M | |
Gross Profit | -- | $2.6M | $21.5M | $68.1M | $116.8M | |
Gross Profit Margin | -- | 81.01% | 90.98% | 87.99% | 89.73% | |
R&D Expenses | $90.5M | $104.1M | $108.6M | $135M | $238M | |
Selling, General & Admin | $46.1M | $68.5M | $92M | $117.5M | $144.3M | |
Other Inc / (Exp) | -- | $100M | -$790K | $190K | $11.1M | |
Operating Expenses | $136.6M | $172.6M | $200.7M | $252.5M | $382.3M | |
Operating Income | -$136.6M | -$170.1M | -$179.2M | -$184.4M | -$265.5M | |
Net Interest Expenses | -- | -- | $1.2M | -- | $5.9M | |
EBT. Incl. Unusual Items | -$134M | -$69.6M | -$181.1M | -$184.1M | -$260.3M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | $564K | $346K | |
Net Income to Company | -$134M | -$69.6M | -$181.1M | -$184.7M | -$260.6M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$134M | -$69.6M | -$181.1M | -$184.7M | -$260.6M | |
Basic EPS (Cont. Ops) | -$3.04 | -$1.40 | -$3.47 | -$3.20 | -$4.34 | |
Diluted EPS (Cont. Ops) | -$3.04 | -$1.40 | -$3.47 | -$3.20 | -$4.34 | |
Weighted Average Basic Share | $44.1M | $49.6M | $52.1M | $57.7M | $61M | |
Weighted Average Diluted Share | $44.1M | $49.6M | $52.1M | $57.7M | $61M | |
EBITDA | -$133.3M | -$68.5M | -$174.2M | -$168.5M | -$238.1M | |
EBIT | -$134M | -$69.6M | -$175.9M | -$170.2M | -$239.7M | |
Revenue (Reported) | -- | $3.2M | $23.6M | $77.4M | $130.1M | |
Operating Income (Reported) | -$136.6M | -$170.1M | -$179.2M | -$184.4M | -$265.5M | |
Operating Income (Adjusted) | -$134M | -$69.6M | -$175.9M | -$170.2M | -$239.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $35K | $1.5M | $11.5M | $26M | $32.7M | |
Revenue Growth (YoY) | -- | 4180% | 665.62% | 126.41% | 25.95% | |
Cost of Revenues | $4K | $230K | $1.4M | $2.8M | $3.6M | |
Gross Profit | $31K | $1.3M | $10M | $23.2M | $29.1M | |
Gross Profit Margin | 88.57% | 84.65% | 87.61% | 89.19% | 88.85% | |
R&D Expenses | $19.9M | $32.5M | $37.9M | $128.7M | $37M | |
Selling, General & Admin | $14.5M | $21.4M | $24.6M | $34.4M | $39.1M | |
Other Inc / (Exp) | $100M | -$233K | -$27K | $524K | -$644K | |
Operating Expenses | $34.4M | $54M | $62.6M | $163M | $76.1M | |
Operating Income | -$34.4M | -$52.7M | -$52.5M | -$139.9M | -$47M | |
Net Interest Expenses | -- | -- | -- | $1.7M | $1.8M | |
EBT. Incl. Unusual Items | $65.8M | -$52.8M | -$52.2M | -$141.1M | -$49.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $22M | -- | -- | $300K | $80K | |
Net Income to Company | $43.8M | -$52.8M | -$52.2M | -$141.4M | -$49.5M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $43.8M | -$52.8M | -$52.2M | -$141.4M | -$49.5M | |
Basic EPS (Cont. Ops) | $0.92 | -$1.05 | -$0.92 | -$2.35 | -$0.81 | |
Diluted EPS (Cont. Ops) | $0.90 | -$1.05 | -$0.92 | -$2.35 | -$0.81 | |
Weighted Average Basic Share | $47.6M | $50.3M | $56.7M | $60.1M | $63.1M | |
Weighted Average Diluted Share | $48.5M | $50.3M | $56.7M | $60.1M | $63.1M | |
EBITDA | -$34.2M | -$52.4M | -$48.7M | -$135.9M | -$43.6M | |
EBIT | -$34.4M | -$52.8M | -$49.1M | -$136.3M | -$44M | |
Revenue (Reported) | $35K | $1.5M | $11.5M | $26M | $32.7M | |
Operating Income (Reported) | -$34.4M | -$52.7M | -$52.5M | -$139.9M | -$47M | |
Operating Income (Adjusted) | -$34.4M | -$52.8M | -$49.1M | -$136.3M | -$44M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | $4.6M | $33.6M | $91.9M | $136.9M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | $825K | $3.3M | $10.7M | $14.2M | |
Gross Profit | $31K | $3.8M | $30.3M | $81.2M | $122.7M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $87.9M | $116.7M | $114.1M | $225.7M | $146.3M | |
Selling, General & Admin | $47.8M | $75.4M | $95.2M | $127.3M | $149M | |
Other Inc / (Exp) | $100M | -$233K | -$950K | $907K | $9.5M | |
Operating Expenses | $135.7M | $192.1M | $209.3M | $352.9M | $295.3M | |
Operating Income | -$135.7M | -$188.4M | -$179M | -$271.7M | -$172.6M | |
Net Interest Expenses | -- | -- | $587K | $2.2M | $5.4M | |
EBT. Incl. Unusual Items | -$34.1M | -$188.1M | -$180.5M | -$273M | -$168.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | $864K | $125K | |
Net Income to Company | -$56.1M | -$166.1M | -$180.5M | -$273.9M | -$168.7M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$56.1M | -$166.1M | -$180.5M | -$273.9M | -$168.7M | |
Basic EPS (Cont. Ops) | -$1.35 | -$3.30 | -$3.35 | -$4.63 | -$2.81 | |
Diluted EPS (Cont. Ops) | -$1.37 | -$3.30 | -$3.35 | -$4.63 | -$2.81 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -$132.4M | -$186.8M | -$170.5M | -$255.5M | -$146.3M | |
EBIT | -$133.1M | -$188.2M | -$172.3M | -$257.3M | -$147.9M | |
Revenue (Reported) | -- | $4.6M | $33.6M | $91.9M | $136.9M | |
Operating Income (Reported) | -$135.7M | -$188.4M | -$179M | -$271.7M | -$172.6M | |
Operating Income (Adjusted) | -$133.1M | -$188.2M | -$172.3M | -$257.3M | -$147.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $35K | $1.5M | $11.5M | $26M | $32.7M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $4K | $230K | $1.4M | $2.8M | $3.6M | |
Gross Profit | $31K | $1.3M | $10M | $23.2M | $29.1M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $19.9M | $32.5M | $37.9M | $128.7M | $37M | |
Selling, General & Admin | $14.5M | $21.4M | $24.6M | $34.4M | $39.1M | |
Other Inc / (Exp) | $100M | -$233K | -$27K | $524K | -$644K | |
Operating Expenses | $34.4M | $54M | $62.6M | $163M | $76.1M | |
Operating Income | -$34.4M | -$52.7M | -$52.5M | -$139.9M | -$47M | |
Net Interest Expenses | -- | -- | -- | $1.7M | $1.8M | |
EBT. Incl. Unusual Items | $65.8M | -$52.8M | -$52.2M | -$141.1M | -$49.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $22M | -- | -- | $300K | $80K | |
Net Income to Company | $43.8M | -$52.8M | -$52.2M | -$141.4M | -$49.5M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $43.8M | -$52.8M | -$52.2M | -$141.4M | -$49.5M | |
Basic EPS (Cont. Ops) | $0.92 | -$1.05 | -$0.92 | -$2.35 | -$0.81 | |
Diluted EPS (Cont. Ops) | $0.90 | -$1.05 | -$0.92 | -$2.35 | -$0.81 | |
Weighted Average Basic Share | $47.6M | $50.3M | $56.7M | $60.1M | $63.1M | |
Weighted Average Diluted Share | $48.5M | $50.3M | $56.7M | $60.1M | $63.1M | |
EBITDA | -$34.2M | -$52.4M | -$48.7M | -$135.9M | -$43.6M | |
EBIT | -$34.4M | -$52.8M | -$49.1M | -$136.3M | -$44M | |
Revenue (Reported) | $35K | $1.5M | $11.5M | $26M | $32.7M | |
Operating Income (Reported) | -$34.4M | -$52.7M | -$52.5M | -$139.9M | -$47M | |
Operating Income (Adjusted) | -$34.4M | -$52.8M | -$49.1M | -$136.3M | -$44M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $100.9M | $59.2M | $127.7M | $60.1M | $89.1M | |
Short Term Investments | $71.9M | $235.6M | $205.6M | $215.8M | $231.4M | |
Accounts Receivable, Net | -- | $1M | $6.2M | $14.9M | $18.5M | |
Inventory | -- | $111K | $2.9M | $8.6M | $18.7M | |
Prepaid Expenses | $5.8M | $8.4M | $4.4M | $2.3M | $7.6M | |
Other Current Assets | $3M | $4M | $7.4M | $6.7M | $8.8M | |
Total Current Assets | $181.7M | $308.4M | $354.2M | $308.3M | $374.2M | |
Property Plant And Equipment | $5M | $4.3M | $3.4M | $2.1M | $4.1M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $403K | $12.1M | $17M | $15.3M | $7.8M | |
Total Assets | $187.1M | $329.5M | $382.5M | $332.7M | $392.3M | |
Accounts Payable | $4.9M | $5.7M | $4.8M | $4.9M | $12.3M | |
Accrued Expenses | $12.4M | $29.3M | $30.5M | $42.9M | $58.3M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $535K | $606K | $684K | $770K | -- | |
Other Current Liabilities | $180K | $800K | $2.4M | $5.4M | $42.1M | |
Total Current Liabilities | $18M | $43.4M | $39.8M | $55.2M | $115.5M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $20.5M | $45.4M | $118.2M | $163M | $227.7M | |
Common Stock | $44K | $50K | $56K | $59K | $142.9M | |
Other Common Equity Adj | $49K | -$1K | -$92K | $134K | -$39K | |
Common Equity | $166.5M | $284.2M | $264.3M | $169.8M | $21.7M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $166.5M | $284.2M | $264.3M | $169.8M | $164.5M | |
Total Liabilities and Equity | $187.1M | $329.5M | $382.5M | $332.7M | $392.3M | |
Cash and Short Terms | $172.8M | $294.9M | $333.3M | $275.8M | $320.6M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $87.3M | $78.5M | $109.7M | $53.4M | $106.1M | |
Short Term Investments | $317.5M | $162.4M | $184.9M | $147.8M | $208.4M | |
Accounts Receivable, Net | -- | $862K | $8.1M | $14.7M | $17.8M | |
Inventory | -- | -- | $5.5M | $8.5M | $19.3M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $7.4M | $11.6M | $9.7M | $11.4M | $17.7M | |
Total Current Assets | $412.1M | $253.4M | $317.8M | $235.8M | $369.3M | |
Property Plant And Equipment | $4.7M | $4.2M | $3.1M | $1.8M | $3.8M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | $7.7M | $6.8M | $6M | |
Other Long-Term Assets | $328K | $18.7M | $17.1M | $14.3M | $7.6M | |
Total Assets | $422.2M | $284.8M | $345.7M | $258.7M | $386.7M | |
Accounts Payable | $9.1M | $12M | $13.3M | $7.6M | $11.9M | |
Accrued Expenses | $6.9M | $23.7M | $27.7M | $36.3M | $53.5M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $553K | $625K | $705K | $793K | $224K | |
Other Current Liabilities | $229K | $1.5M | $2.8M | $8.2M | $44.6M | |
Total Current Liabilities | $16.9M | $47.3M | $46M | $54.2M | $111.8M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $41.3M | $49.1M | $125.9M | $197.1M | $223.6M | |
Common Stock | $50K | $50K | $56K | $60K | $144.2M | |
Other Common Equity Adj | -$58K | -$629K | -$6K | -$181K | -$51K | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $380.9M | $235.8M | $219.8M | $61.6M | $163.1M | |
Total Liabilities and Equity | $422.2M | $284.8M | $345.7M | $258.7M | $386.7M | |
Cash and Short Terms | $404.8M | $241M | $294.6M | $201.2M | $314.5M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$134M | -$69.6M | -$181.1M | -$184.7M | -$260.6M | |
Depreciation & Amoritzation | $690K | $1.2M | $1.7M | $1.8M | $1.6M | |
Stock-Based Compensation | $17.5M | $20.8M | $19.8M | $32.6M | $39.7M | |
Change in Accounts Receivable | -- | -$1.3M | -$5.2M | -$8.6M | -$3.6M | |
Change in Inventories | -- | -$11K | -$2.8M | -$5.7M | -$10.1M | |
Cash From Operations | -$122M | -$146M | -$173.4M | -$136.2M | -$113.9M | |
Capital Expenditures | -- | $5.4M | $4.3M | $47K | -- | |
Cash Acquisitions | -- | $100M | -- | -- | -- | |
Cash From Investing | $158.5M | -$62.2M | $28M | -$5.7M | -$48.2M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | $72.3M | $17M | -$4M | |
Cash From Financing | $2M | $166.5M | $213.8M | $74.4M | $191.2M | |
Beginning Cash (CF) | $62.7M | $101.3M | $59.6M | $128M | $60.4M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $38.6M | -$41.7M | $68.4M | -$67.5M | $29.2M | |
Ending Cash (CF) | $101.3M | $59.6M | $128M | $60.4M | $89.6M | |
Levered Free Cash Flow | -$122.2M | -$151.4M | -$177.7M | -$136.2M | -$113.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $43.8M | -$52.8M | -$52.2M | -$141.4M | -$49.5M | |
Depreciation & Amoritzation | $201K | $350K | $457K | $405K | $383K | |
Stock-Based Compensation | $5.2M | $4.6M | $6.4M | $7.8M | $12.9M | |
Change in Accounts Receivable | -- | -- | -$1.9M | $172K | $687K | |
Change in Inventories | -- | -- | -$2.6M | $117K | -$575K | |
Cash From Operations | -$33.5M | -$53.6M | -$36.4M | -$40.7M | -$40.4M | |
Capital Expenditures | $12K | $127K | $47K | $40M | -- | |
Cash Acquisitions | $100M | -- | -- | -- | -- | |
Cash From Investing | -$145.7M | $72.5M | $18.5M | $30.1M | $24.8M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -$1.4M | -$2.8M | -$4.6M | |
Cash From Financing | $165.6M | $399K | -$133K | $4.2M | $32.5M | |
Beginning Cash (CF) | $101.3M | $59.6M | $128M | $60.4M | $89.6M | |
Foreign Exchange Rate Adjustment | -- | -- | $86K | -$71K | -$2K | |
Additions / Reductions | -$13.7M | $19.3M | -$18.1M | -$6.5M | $17M | |
Ending Cash (CF) | $87.6M | $78.9M | $110M | $53.9M | $106.6M | |
Levered Free Cash Flow | -$33.5M | -$53.8M | -$36.5M | -$80.7M | -$40.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$56.1M | -$166.1M | -$180.5M | -$273.9M | -$168.7M | |
Depreciation & Amoritzation | $724K | $1.3M | $1.8M | $1.7M | $1.5M | |
Stock-Based Compensation | $17.2M | $20.2M | $21.6M | $33.9M | $44.8M | |
Change in Accounts Receivable | -- | -- | -$7.1M | -$6.6M | -$3.1M | |
Change in Inventories | -- | -- | -$5.4M | -$3M | -$10.8M | |
Cash From Operations | -$119.4M | -$166.1M | -$156.2M | -$140.5M | -$113.5M | |
Capital Expenditures | $12K | $5.5M | $4.2M | $40M | -$40M | |
Cash Acquisitions | $100M | -- | -- | -- | -- | |
Cash From Investing | -$16.1M | $156.1M | -$26M | $5.9M | -$53.4M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | $71M | $15.5M | -$5.8M | |
Cash From Financing | $166.9M | $1.3M | $213.3M | $78.7M | $219.5M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $31.4M | -$8.7M | $31M | -$55.8M | $52.6M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$119.6M | -$171.7M | -$160.4M | -$180.5M | -$113.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $43.8M | -$52.8M | -$52.2M | -$141.4M | -$49.5M | |
Depreciation & Amoritzation | $201K | $350K | $457K | $405K | $383K | |
Stock-Based Compensation | $5.2M | $4.6M | $6.4M | $7.8M | $12.9M | |
Change in Accounts Receivable | -- | -- | -$1.9M | $172K | $687K | |
Change in Inventories | -- | -- | -$2.6M | $117K | -$575K | |
Cash From Operations | -$33.5M | -$53.6M | -$36.4M | -$40.7M | -$40.4M | |
Capital Expenditures | $12K | $127K | $47K | $40M | -- | |
Cash Acquisitions | $100M | -- | -- | -- | -- | |
Cash From Investing | -$145.7M | $72.5M | $18.5M | $30.1M | $24.8M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -$1.4M | -$2.8M | -$4.6M | |
Cash From Financing | $165.6M | $399K | -$133K | $4.2M | $32.5M | |
Beginning Cash (CF) | $101.3M | $59.6M | $128M | $60.4M | $89.6M | |
Foreign Exchange Rate Adjustment | -- | -- | $86K | -$71K | -$2K | |
Additions / Reductions | -$13.7M | $19.3M | -$18.1M | -$6.5M | $17M | |
Ending Cash (CF) | $87.6M | $78.9M | $110M | $53.9M | $106.6M | |
Levered Free Cash Flow | -$33.5M | -$53.8M | -$36.5M | -$80.7M | -$40.4M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.